Gefitinib Radiosensitizes Non-Small Cell Lung Cancer Cells Through Inhibition of Ataxia Telangiectasia Mutated

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-9-222
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

ERK Inhibition Represses Gefitinib Resistance in Non-Small Cell Lung Cancer Cells

Oncotarget
Oncology
2018English

Inhibition of SREBP Increases Gefitinib Sensitivity in Non-Small Cell Lung Cancer Cells

Oncotarget
Oncology
2016English

ATM (Ataxia Telangiectasia Mutated)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Icotinib Is as Efficacious as Gefitinib for Brain Metastasis of EGFR Mutated Non-Small-Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Inhibition of Cell Proliferation and Migration in Non‑small Cell Lung Cancer Cells Through the Suppression of LYPLA1

Oncology Reports
MedicineCancer ResearchOncology
2018English

Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Management of Patients With Advanced Non-Small Cell Lung Cancer: Role of Gefitinib

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Adenovirus-Mediated P16INK4a Gene Expression Radiosensitizes Non-Small Cell Lung Cancer Cells in a P53-Dependent Manner

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy